Day case discharge of patients treated with drug coated balloon only angioplasty for de novo coronary artery disease: A single center experience.
To report our initial experience with drug coated balloon (DCB) only angioplasty and propose a protocol to achieve this safely. There are no articles published in the literature currently regarding the safety of same day discharge in patients treated with DCB-only angioplasty. Retrospective review of all our patients treated with DCB-only angioplasty from September 2017 to April 2018 with identification of potential complications relating to same day discharge. A total of 100 consecutive patients who underwent elective DCB-only angioplasty for de novo coronary artery disease and were discharged on the same day as the procedure were included. In 99% no cardiac symptoms relating to the procedure requiring urgent hospitalization or urgent investigations were identified. One patient was readmitted the next day requiring stenting of the previously treated lesion. Our 30-day mortality was zero. Some 97 hospital bed days were saved with 100 patients treated. Elective day-case DCB-only angioplasty according to our local protocol is safe and cost-effective and should be considered for the majority of the patients.